TA
Tanvir Ahmed Khan Mahadik
About Tanvir Ahmed Khan Mahadik
Data last updated:
Tanvir Ahmed Khan Mahadik is a Whole-Time Director at Maxim Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Maxim Pharmaceuticals Private Limited reported revenue of ₹129 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Maxim Pharmaceuticals Private Limited U24239PN1998PTC013106 | Whole-Time Director | 01 Jul 2017 | 1998 | ₹129 Cr (FY 2025) | Active |
Board colleagues of Tanvir Ahmed Khan Mahadik
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Kundanmal Dhoka | 00409742 | Maxim Pharmaceuticals Private Limited | Managing Director |
| Manju Ashok Dhoka | 00507112 | Maxim Pharmaceuticals Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tanvir Ahmed Khan Mahadik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tanvir Ahmed Khan Mahadik
Tanvir Ahmed Khan Mahadik currently holds 1 directorship: Maxim Pharmaceuticals Private Limited (Whole-Time Director, since 01 Jul 2017, revenue ₹129 Cr (FY 2025)).
Tanvir Ahmed Khan Mahadik was first appointed on 01 Jul 2017 as Whole-Time Director at Maxim Pharmaceuticals Private Limited.
The current boards of Tanvir Ahmed Khan Mahadik's companies include Ashok Kundanmal Dhoka (Maxim Pharmaceuticals Private Limited), Manju Ashok Dhoka (Maxim Pharmaceuticals Private Limited).